Showing results (291-300 of 514) with videos related to
Sort By:
Pageof 52
Journal of Neurosurgery. Pediatrics|August 3, 2010
Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT databaseMartin Benesch, Daniela Weber-Mzell, Nicolas U Gerber, et al.Acta Neuropathologica|September 2, 2019
FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomasFrank Brand, Alisa Förster, Anne Christians, et al.Clinical Neuropathology|May 1, 2020
Quality assurance in neuropathology: Experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019Markus J Riemenschneider, Josephine Fischer, Maja Grassow-Narlik, et al.Cancer Research|February 4, 2010
Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cellsAnke Waha, Jörg Felsberg, Wolfgang Hartmann, et al.Frontiers in Oncology|December 14, 2023
Case Report: Remarkable breakthrough: successful treatment of a rare intracranial mesenchymal, FET::CREB fusion-positive tumor treated with patient-tailored multimodal therapyFederica D'Antonio, Sabrina Rossi, Isabella Giovannoni, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|October 20, 2025
Acromegaly and Morris Syndrome: Description of a Clinical CaseSimone Antonio De Sanctis, Sabrina Chiloiro, Antonella Giampietro, et al.International Journal of Molecular Sciences|April 30, 2021
Combining Magnetic Resonance Imaging with Systemic Monocyte Evaluation for the Implementation of GBM ManagementCarolina Giordano, Giovanni Sabatino, Simona Romano, et al.Journal of Neuro-Oncology|February 11, 2011
Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006Nicolas U Gerber, Katja von Hoff, André O von Bueren, et al.Neuro-Oncology|October 20, 2017
Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trialGabriele Calaminus, Didier Frappaz, Rolf Dieter Kortmann, et al.International Journal of Cancer|March 12, 2014
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapyMichael Weller, Kerstin Kaulich, Bettina Hentschel, et al.Pageof 52